{"transactions":[{"id":230,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2026-08-31","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.05,"value":5000.0,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive."}],"balance_after":690167,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":229,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":94767,"price":0.06,"value":5686.02,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive."}],"balance_after":590167,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":228,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.05,"value":2500.0,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive."}],"balance_after":495400,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":227,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2026-08-25","kind":"purchase","planned":false,"acquired":true,"shares":46000,"price":0.04,"value":1840.0,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive."}],"balance_after":445400,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":226,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2025-08-29","kind":"purchase","planned":false,"acquired":true,"shares":170000,"price":0.01,"value":1700.0,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive."}],"balance_after":275400,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":225,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2026-09-02T19:05:38.000Z","date":"2025-05-30","kind":"purchase","planned":false,"acquired":true,"shares":70000,"price":0.02,"value":1400.0,"ownership":{"direct":false,"nature":"Fidelity Roth IRA FBO Willis C. Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6)."}],"balance_after":229400,"source":{"system":"sec-edgar","filing":"0001193125-26-380023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517775/000119312526380023/ownership.xml","form_type":"4"}},{"id":1404173,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2024-09-18T15:40:08.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.04,"value":800.0,"ownership":{"direct":true},"balance_after":4606626,"source":{"system":"sec-edgar","filing":"0000950170-24-107658","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000095017024107658/ownership.xml","form_type":"4"}},{"id":1611123,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-02-29T23:11:11.000Z","date":"2024-02-29","kind":"purchase","planned":false,"acquired":true,"shares":77000,"price":0.13,"value":10010.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":159400,"source":{"system":"sec-edgar","filing":"0001209191-24-004124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124004124/doc4.xml","form_type":"4"}},{"id":1611122,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-02-29T23:11:11.000Z","date":"2024-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.12,"value":1800.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive."}],"balance_after":82400,"source":{"system":"sec-edgar","filing":"0001209191-24-004124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124004124/doc4.xml","form_type":"4"}},{"id":1611121,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-02-29T23:11:11.000Z","date":"2024-02-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.13,"value":1300.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":67400,"source":{"system":"sec-edgar","filing":"0001209191-24-004124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124004124/doc4.xml","form_type":"4"}},{"id":1611120,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-02-29T23:11:11.000Z","date":"2024-02-26","kind":"purchase","planned":false,"acquired":true,"shares":13200,"price":0.12,"value":1584.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4."}],"balance_after":57400,"source":{"system":"sec-edgar","filing":"0001209191-24-004124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124004124/doc4.xml","form_type":"4"}},{"id":1660025,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94644,"kind":"person","name":"Zwicker Ian Harvey","position":1,"cik":"0001642012","reported_name":"Zwicker Ian Harvey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2024-02-05T21:40:23.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0.15,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2024"}],"balance_after":100000,"derivative":{"exercise_price":0.15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-24-002819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002819/doc4.xml","form_type":"4"}},{"id":1660024,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94643,"kind":"person","name":"ZEN Wei Peu","position":1,"cik":"0001746204","reported_name":"ZEN Wei Peu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2024-02-05T21:39:29.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0.15,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2024"}],"balance_after":100000,"derivative":{"exercise_price":0.15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-24-002815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002815/doc4.xml","form_type":"4"}},{"id":1660023,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2024-02-05T21:38:23.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0.15,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2024"}],"balance_after":100000,"derivative":{"exercise_price":0.15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-24-002811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002811/doc4.xml","form_type":"4"}},{"id":1660021,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94641,"kind":"person","name":"Stark Charles William","position":1,"cik":"0001901666","reported_name":"Stark Charles William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Clinical Development"}}],"security":"Options","published_at":"2024-02-05T21:37:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.15,"value":30000.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.15,"exercise_date":"2024-02-01","expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-24-002804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002804/doc4.xml","form_type":"4"}},{"id":1660022,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94642,"kind":"person","name":"Sekulich George","position":1,"cik":"0001896627","reported_name":"Sekulich George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & CCO"}}],"security":"Options","published_at":"2024-02-05T21:35:30.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.15,"value":30000.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.15,"exercise_date":"2024-02-01","expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-24-002798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002798/doc4.xml","form_type":"4"}},{"id":1660020,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94640,"kind":"person","name":"NAGASAKI YASUSHI","position":1,"cik":"0001517916","reported_name":"NAGASAKI YASUSHI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Options","published_at":"2024-02-05T21:34:12.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.15,"value":30000.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.15,"exercise_date":"2024-02-01","expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-24-002795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002795/doc4.xml","form_type":"4"}},{"id":1660019,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President & COO"}}],"security":"Options","published_at":"2024-02-05T21:32:13.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.15,"value":30000.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.15,"exercise_date":"2024-02-01","expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-24-002790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124002790/doc4.xml","form_type":"4"}},{"id":1695112,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":59400,"price":0.12,"value":7128.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive."}],"balance_after":395124,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1695111,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":36000,"price":0.12,"value":4320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive."}],"balance_after":335724,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1695110,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-11-28","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":0.12,"value":1440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4."}],"balance_after":299724,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1695109,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":0.12,"value":132.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":44200,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1695108,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":0.15,"value":900.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":43100,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1695107,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2024-01-03T21:59:57.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":0.21,"value":1365.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":37100,"source":{"system":"sec-edgar","filing":"0001209191-24-000442","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919124000442/doc4a.xml","form_type":"4/A","original_submission_date":"2023-12-04"}},{"id":1702802,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-21T16:34:54.000Z","date":"2023-12-20","kind":"sale","planned":false,"acquired":false,"shares":32500,"price":0.05,"value":1625.0,"ownership":{"direct":true},"balance_after":4586626,"source":{"system":"sec-edgar","filing":"0001209191-23-059399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059399/doc4.xml","form_type":"4"}},{"id":1705981,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Promissory Note due 9/16/2025","published_at":"2023-12-20T00:44:30.000Z","date":"2023-12-15","kind":"other","planned":false,"acquired":false,"shares":240000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represent shares previously issuable upon maturity of the Promissory Note due 9/16/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":0.29,"underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705980,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2023-12-15","kind":"other","planned":false,"acquired":true,"shares":4447426,"price":0.29,"value":1289753.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation."}],"balance_after":4619126,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705979,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2023-12-15","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":0.11,"value":660.0,"ownership":{"direct":true},"balance_after":171700,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705978,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":1700,"price":0.15,"value":255.0,"ownership":{"direct":true},"balance_after":177700,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705977,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.15,"value":3000.0,"ownership":{"direct":true},"balance_after":176000,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705976,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":92100,"price":0.27,"value":24867.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.27, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."}],"balance_after":156000,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705975,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:44:30.000Z","date":"2022-10-09","kind":"purchase","planned":false,"acquired":true,"shares":25400,"price":0.11,"value":2794.0,"ownership":{"direct":true},"balance_after":63900,"source":{"system":"sec-edgar","filing":"0001209191-23-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059268/doc4.xml","form_type":"4"}},{"id":1705974,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94643,"kind":"person","name":"ZEN Wei Peu","position":1,"cik":"0001746204","reported_name":"ZEN Wei Peu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note dated 2023-01-18","published_at":"2023-12-20T00:40:45.000Z","date":"2023-01-18","kind":"other","planned":false,"acquired":false,"shares":2000000,"price":0.5,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represent shares previously issuable upon conversion of the Convertible Promissory Note."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above."}],"balance_after":0,"derivative":{"exercise_price":0.5,"underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-23-059265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059265/doc4.xml","form_type":"4"}},{"id":1705973,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94643,"kind":"person","name":"ZEN Wei Peu","position":1,"cik":"0001746204","reported_name":"ZEN Wei Peu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-20T00:40:45.000Z","date":"2023-12-15","kind":"other","planned":false,"acquired":true,"shares":3760983,"price":0.29,"value":1090685.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation."}],"balance_after":4768817,"source":{"system":"sec-edgar","filing":"0001209191-23-059265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123059265/doc4.xml","form_type":"4"}},{"id":1724620,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":7417,"price":0.12,"value":890.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive."}],"balance_after":395124,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1724619,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":4325,"price":0.12,"value":519.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive."}],"balance_after":335724,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1724618,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-11-28","kind":"purchase","planned":false,"acquired":true,"shares":1470,"price":0.12,"value":176.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4."}],"balance_after":299724,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1724617,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":132,"price":0.12,"value":15.84,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":44200,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1724616,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":0.15,"value":135.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":43100,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1724615,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-12-05T01:33:02.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":1365,"price":0.21,"value":286.65,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":37100,"source":{"system":"sec-edgar","filing":"0001209191-23-057328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123057328/doc4.xml","form_type":"4"}},{"id":1871110,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-06-02T17:23:42.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":28700,"price":0.29,"value":8323.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.28 to $0.32, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."}],"balance_after":30600,"source":{"system":"sec-edgar","filing":"0001209191-23-033573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123033573/doc4.xml","form_type":"4"}},{"id":1871109,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2023-06-02T17:23:42.000Z","date":"2022-09-20","kind":"purchase","planned":false,"acquired":true,"shares":750,"price":0.28,"value":210.0,"ownership":{"direct":true},"balance_after":287724,"source":{"system":"sec-edgar","filing":"0001209191-23-033573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123033573/doc4.xml","form_type":"4"}},{"id":2050097,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94643,"kind":"person","name":"ZEN Wei Peu","position":1,"cik":"0001746204","reported_name":"ZEN Wei Peu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note dated 2023-01-18","published_at":"2023-01-20T16:40:58.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":2000000,"price":0.5,"value":1000000.0,"ownership":{"direct":true},"balance_after":2000000,"derivative":{"exercise_price":0.5,"exercise_date":"2023-01-18","expiration_date":"2025-01-17","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-23-004167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123004167/doc4.xml","form_type":"4"}},{"id":2051651,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Options","published_at":"2023-01-19T22:54:15.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":500000,"price":4.5,"value":2250000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary."}],"balance_after":500000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-004070","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123004070/doc4a.xml","form_type":"4/A","original_submission_date":"2023-01-17"}},{"id":2054158,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94644,"kind":"person","name":"Zwicker Ian Harvey","position":1,"cik":"0001642012","reported_name":"Zwicker Ian Harvey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2023-01-17T19:36:53.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":100000,"price":4.5,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2023"}],"balance_after":100000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-003472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003472/doc4.xml","form_type":"4"}},{"id":2054157,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94643,"kind":"person","name":"ZEN Wei Peu","position":1,"cik":"0001746204","reported_name":"ZEN Wei Peu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2023-01-17T19:35:49.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":100000,"price":4.5,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2023"}],"balance_after":100000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-003470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003470/doc4.xml","form_type":"4"}},{"id":2054155,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":87460,"kind":"person","name":"Lim Seah H.","position":1,"cik":"0001949484","reported_name":"Lim Seah H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2023-01-17T19:34:14.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":100000,"price":4.5,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments as of the last day of each quarter beginning on March 31, 2023"}],"balance_after":100000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-003468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003468/doc4.xml","form_type":"4"}},{"id":2054156,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94641,"kind":"person","name":"Stark Charles William","position":1,"cik":"0001901666","reported_name":"Stark Charles William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Options","published_at":"2023-01-17T19:32:23.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":100000,"price":4.5,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary."}],"balance_after":100000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-003466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003466/doc4.xml","form_type":"4"}},{"id":2054154,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94642,"kind":"person","name":"Sekulich George","position":1,"cik":"0001896627","reported_name":"Sekulich George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CIO & SVP"}}],"security":"Options","published_at":"2023-01-17T19:31:02.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":100000,"price":4.5,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary."}],"balance_after":100000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-003464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003464/doc4.xml","form_type":"4"}},{"id":2054153,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":94640,"kind":"person","name":"NAGASAKI YASUSHI","position":1,"cik":"0001517916","reported_name":"NAGASAKI YASUSHI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Options","published_at":"2023-01-17T19:29:30.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":150000,"price":4.5,"value":675000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary."}],"balance_after":150000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-003462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003462/doc4.xml","form_type":"4"}},{"id":2054152,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Options","published_at":"2023-01-17T19:27:49.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":750000,"price":4.5,"value":3375000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary."}],"balance_after":750000,"derivative":{"exercise_price":4.5,"expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001209191-23-003460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003460/doc4.xml","form_type":"4"}},{"id":2054151,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Warrants (right to buy)","published_at":"2023-01-17T18:59:20.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":7500000,"price":4.5,"value":33750000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.5,"exercise_date":"2023-01-12","expiration_date":"2028-01-11","underlying":"Common Stock","underlying_shares":7500000},"source":{"system":"sec-edgar","filing":"0001209191-23-003457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919123003457/doc4.xml","form_type":"4"}},{"id":2100611,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-12-01T18:35:44.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":22900,"price":0.41,"value":9389.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.44, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":12040857,"source":{"system":"sec-edgar","filing":"0001209191-22-059154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122059154/doc4.xml","form_type":"4"}},{"id":2100610,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-12-01T18:35:44.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":14700,"price":0.38,"value":5586.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.36 to $0.40, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":12017957,"source":{"system":"sec-edgar","filing":"0001209191-22-059154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122059154/doc4.xml","form_type":"4"}},{"id":2100609,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-12-01T18:35:44.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":5000,"price":0.35,"value":1750.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":12003257,"source":{"system":"sec-edgar","filing":"0001209191-22-059154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122059154/doc4.xml","form_type":"4"}},{"id":2100608,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-12-01T18:35:44.000Z","date":"2022-11-04","kind":"purchase","acquired":true,"shares":7500,"price":0.45,"value":3375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11998257,"source":{"system":"sec-edgar","filing":"0001209191-22-059154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122059154/doc4.xml","form_type":"4"}},{"id":2100607,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-12-01T18:35:44.000Z","date":"2022-11-03","kind":"purchase","acquired":true,"shares":2500,"price":0.45,"value":1125.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11990757,"source":{"system":"sec-edgar","filing":"0001209191-22-059154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122059154/doc4.xml","form_type":"4"}},{"id":2126505,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-11-03T18:50:18.000Z","date":"2022-11-02","kind":"purchase","acquired":true,"shares":15000,"price":0.43,"value":6450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.42 to $0.45, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11988257,"source":{"system":"sec-edgar","filing":"0001209191-22-055471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122055471/doc4.xml","form_type":"4"}},{"id":2126504,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-11-03T18:50:18.000Z","date":"2022-11-01","kind":"purchase","acquired":true,"shares":5000,"price":0.43,"value":2150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.42 to $0.44, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11973257,"source":{"system":"sec-edgar","filing":"0001209191-22-055471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122055471/doc4.xml","form_type":"4"}},{"id":2126503,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-11-03T18:50:18.000Z","date":"2022-10-31","kind":"purchase","acquired":true,"shares":7500,"price":0.45,"value":3375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.44 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11968257,"source":{"system":"sec-edgar","filing":"0001209191-22-055471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122055471/doc4.xml","form_type":"4"}},{"id":2130108,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-31T18:59:29.000Z","date":"2022-10-28","kind":"purchase","acquired":true,"shares":7500,"price":0.42,"value":3150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.47, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11960757,"source":{"system":"sec-edgar","filing":"0001209191-22-054902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054902/doc4.xml","form_type":"4"}},{"id":2130107,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-31T18:59:29.000Z","date":"2022-10-27","kind":"purchase","acquired":true,"shares":22500,"price":0.27,"value":6075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.26 to $0.35, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11953257,"source":{"system":"sec-edgar","filing":"0001209191-22-054902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054902/doc4.xml","form_type":"4"}},{"id":2130106,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-31T18:59:29.000Z","date":"2022-10-26","kind":"purchase","acquired":true,"shares":11900,"price":0.27,"value":3213.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.25 to $0.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11930757,"source":{"system":"sec-edgar","filing":"0001209191-22-054902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054902/doc4.xml","form_type":"4"}},{"id":2130105,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-31T18:59:29.000Z","date":"2022-10-25","kind":"purchase","acquired":true,"shares":20000,"price":0.26,"value":5200.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11918857,"source":{"system":"sec-edgar","filing":"0001209191-22-054902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054902/doc4.xml","form_type":"4"}},{"id":2130104,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-31T18:59:29.000Z","date":"2022-10-24","kind":"purchase","acquired":true,"shares":7500,"price":0.22,"value":1650.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11898857,"source":{"system":"sec-edgar","filing":"0001209191-22-054902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054902/doc4.xml","form_type":"4"}},{"id":2133260,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-24T22:34:49.000Z","date":"2022-10-21","kind":"purchase","acquired":true,"shares":10000,"price":0.19,"value":1900.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11891357,"source":{"system":"sec-edgar","filing":"0001209191-22-054449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054449/doc4.xml","form_type":"4"}},{"id":2133259,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-24T22:34:49.000Z","date":"2022-10-20","kind":"purchase","acquired":true,"shares":30000,"price":0.18,"value":5400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.17 to $0.21, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11881357,"source":{"system":"sec-edgar","filing":"0001209191-22-054449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054449/doc4.xml","form_type":"4"}},{"id":2133258,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-24T22:34:49.000Z","date":"2022-10-19","kind":"purchase","acquired":true,"shares":25000,"price":0.16,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11851357,"source":{"system":"sec-edgar","filing":"0001209191-22-054449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054449/doc4.xml","form_type":"4"}},{"id":2135134,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-19T18:21:07.000Z","date":"2022-10-18","kind":"purchase","acquired":true,"shares":30000,"price":0.19,"value":5700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.17 to $0.20, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11826357,"source":{"system":"sec-edgar","filing":"0001209191-22-054051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054051/doc4.xml","form_type":"4"}},{"id":2135133,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-19T18:21:07.000Z","date":"2022-10-17","kind":"purchase","acquired":true,"shares":15000,"price":0.2,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.22, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11796357,"source":{"system":"sec-edgar","filing":"0001209191-22-054051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122054051/doc4.xml","form_type":"4"}},{"id":2136674,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-17T17:01:25.000Z","date":"2022-10-14","kind":"purchase","acquired":true,"shares":35000,"price":0.17,"value":5950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.18, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11781357,"source":{"system":"sec-edgar","filing":"0001209191-22-053757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053757/doc4.xml","form_type":"4"}},{"id":2136673,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-17T17:01:25.000Z","date":"2022-10-13","kind":"purchase","acquired":true,"shares":62500,"price":0.18,"value":11250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.10 to $0.31, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11746357,"source":{"system":"sec-edgar","filing":"0001209191-22-053757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053757/doc4.xml","form_type":"4"}},{"id":2137949,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-13T20:05:17.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":160000,"price":0.08,"value":12800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.07 to $0.09, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11683857,"source":{"system":"sec-edgar","filing":"0001209191-22-053559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053559/doc4.xml","form_type":"4"}},{"id":2137948,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-13T20:05:17.000Z","date":"2022-10-11","kind":"purchase","acquired":true,"shares":5000,"price":0.09,"value":450.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11523857,"source":{"system":"sec-edgar","filing":"0001209191-22-053559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053559/doc4.xml","form_type":"4"}},{"id":2138679,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-11","kind":"purchase","acquired":true,"shares":130000,"price":0.09,"value":11700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.08 to $0.12, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11518857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138678,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-10","kind":"purchase","acquired":true,"shares":10000,"price":0.09,"value":900.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11388857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138677,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-07","kind":"purchase","acquired":true,"shares":4000,"price":0.13,"value":520.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11378857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138676,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-06","kind":"purchase","acquired":true,"shares":5000,"price":0.15,"value":750.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11374857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138675,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":10000,"price":0.15,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11369857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138674,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-04","kind":"purchase","acquired":true,"shares":5000,"price":0.16,"value":800.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11359857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138673,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-10-03","kind":"purchase","acquired":true,"shares":10000,"price":0.2,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11354857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138672,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-09-27","kind":"purchase","acquired":true,"shares":5000,"price":0.2,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11344857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2138671,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-10-12T17:04:08.000Z","date":"2022-09-26","kind":"purchase","acquired":true,"shares":6000,"price":0.2,"value":1200.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11339857,"source":{"system":"sec-edgar","filing":"0001209191-22-053433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122053433/doc4.xml","form_type":"4"}},{"id":2202960,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-07-25T16:49:47.000Z","date":"2022-07-19","kind":"purchase","acquired":true,"shares":3200,"price":0.39,"value":1248.0,"ownership":{"direct":true},"balance_after":286974,"source":{"system":"sec-edgar","filing":"0001209191-22-043081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122043081/doc4.xml","form_type":"4"}},{"id":2246187,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-06-03T15:52:43.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":2500,"price":0.4,"value":1000.0,"ownership":{"direct":true},"balance_after":283774,"source":{"system":"sec-edgar","filing":"0001209191-22-033847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122033847/doc4.xml","form_type":"4"}},{"id":2246186,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-06-03T15:52:43.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":2500,"price":0.37,"value":925.0,"ownership":{"direct":true},"balance_after":281274,"source":{"system":"sec-edgar","filing":"0001209191-22-033847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122033847/doc4.xml","form_type":"4"}},{"id":2248394,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-06-02T23:49:45.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":2000,"price":0.5,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11333857,"source":{"system":"sec-edgar","filing":"0001209191-22-033730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122033730/doc4.xml","form_type":"4"}},{"id":2248393,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-06-02T23:49:45.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":5000,"price":0.49,"value":2450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.48 to $0.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11331857,"source":{"system":"sec-edgar","filing":"0001209191-22-033730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122033730/doc4.xml","form_type":"4"}},{"id":2264703,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-05-19T18:45:22.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":7351,"price":0.35,"value":2572.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.28 to $0.40, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11326857,"source":{"system":"sec-edgar","filing":"0001209191-22-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122030451/doc4.xml","form_type":"4"}},{"id":2264702,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-05-19T18:45:22.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":10000,"price":0.34,"value":3400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.33 to $0.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11319506,"source":{"system":"sec-edgar","filing":"0001209191-22-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122030451/doc4.xml","form_type":"4"}},{"id":2264701,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-05-19T18:45:22.000Z","date":"2022-05-09","kind":"purchase","acquired":true,"shares":6000,"price":0.6,"value":3600.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11309506,"source":{"system":"sec-edgar","filing":"0001209191-22-030451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122030451/doc4.xml","form_type":"4"}},{"id":2298952,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-04-12T19:59:51.000Z","date":"2022-04-11","kind":"purchase","acquired":true,"shares":8900,"price":0.88,"value":7832.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.89, inclusive."}],"balance_after":278774,"source":{"system":"sec-edgar","filing":"0001209191-22-024129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122024129/doc4.xml","form_type":"4"}},{"id":2298951,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-04-12T19:59:51.000Z","date":"2022-04-08","kind":"purchase","acquired":true,"shares":1600,"price":0.76,"value":1216.0,"ownership":{"direct":false,"nature":"By Fidelity Traditional IRA FBO Willis C.  Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.78, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4."}],"balance_after":241194,"source":{"system":"sec-edgar","filing":"0001209191-22-024129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122024129/doc4.xml","form_type":"4"}},{"id":2298950,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-04-12T19:59:51.000Z","date":"2022-04-06","kind":"purchase","acquired":true,"shares":1400,"price":0.95,"value":1330.0,"ownership":{"direct":false,"nature":"By Fidelity Traditional IRA FBO Willis C.  Lee"},"balance_after":239594,"source":{"system":"sec-edgar","filing":"0001209191-22-024129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122024129/doc4.xml","form_type":"4"}},{"id":2298949,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-04-12T19:59:51.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":3200,"price":0.98,"value":3136.0,"ownership":{"direct":false,"nature":"By Fidelity Traditional IRA FBO Willis C.  Lee"},"balance_after":238194,"source":{"system":"sec-edgar","filing":"0001209191-22-024129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122024129/doc4.xml","form_type":"4"}},{"id":2363017,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":120690,"kind":"person","name":"Niihara Yutaka","position":1,"cik":"0001517691","reported_name":"Niihara Yutaka","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-03-02T22:55:49.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":53800,"price":1.49,"value":80162.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.70, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife."}],"balance_after":11303506,"source":{"system":"sec-edgar","filing":"0001209191-22-014998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122014998/doc4.xml","form_type":"4"}},{"id":2370323,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-02-28T22:34:40.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":900,"price":1.65,"value":1485.0,"ownership":{"direct":false,"nature":"By Fidelity Roth IRA FBO Willis C.  Lee"},"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001209191-22-013725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122013725/doc4.xml","form_type":"4"}},{"id":2370322,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-02-28T22:34:40.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":6600,"price":1.5,"value":9900.0,"ownership":{"direct":false,"nature":"By Fidelity Traditional IRA FBO Willis C.  Lee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.60, inclusive."}],"balance_after":234994,"source":{"system":"sec-edgar","filing":"0001209191-22-013725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122013725/doc4.xml","form_type":"4"}},{"id":2370321,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-02-28T22:34:40.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":7200,"price":1.51,"value":10872.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.54, inclusive."}],"balance_after":269874,"source":{"system":"sec-edgar","filing":"0001209191-22-013725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122013725/doc4.xml","form_type":"4"}},{"id":2370320,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":206,"kind":"person","name":"LEE WILLIS C","position":1,"cik":"0001517775","reported_name":"LEE WILLIS C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman & COO"}}],"security":"Common stock, $0.001 par value","published_at":"2022-02-28T22:34:40.000Z","date":"2022-02-24","kind":"purchase","acquired":true,"shares":5900,"price":1.44,"value":8496.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4."}],"balance_after":262674,"source":{"system":"sec-edgar","filing":"0001209191-22-013725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000120919122013725/doc4.xml","form_type":"4"}}],"next_cursor":"2022-02-28T22:34:40.000000Z,2370320"}